Neuromuscular diseases Dystrophie musculaire Myogenesis Titin Dynamin 2 Muscle POPDC1 Myopathy COL1A1 Rare neuromuscular diseases Muscular dystrophy MD Hypermobile EDS C2C12 CMTX Clinical trial Muscle biopsy Biological sciences Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Adult SMA Emerin Mouse Actionability Laminopathy Exome GNE Muscular dystrophy Maladies rares et orphelines Ehlers‐Danlos Syndrome Regeneration Alternative splicing Allele‐specific silencing therapy AAV VECTOR IPSC LGMD Base de données FAIR Congenital muscular dystrophy BiP Centronuclear myopathy Myologie Duchenne muscular dystrophy C elegans Mutations LMNA LMNA-related congenital muscular dystrophy Actionable gene Treatment Diagnosis Connective tissue Lamin A/C Nuclear envelope Joint laxity Dystrophine Myopathies COVID-19 CRISPR Lamin A/C LMNA gene CSF protein Patient registry A-type lamins Calcium handling BVES A-type lamin Lamins Biomarker Allele-specific silencing Therapy Skeletal muscle Dilated cardiomyopathy Cancer biomarkers Heart Angiotensin-converting enzyme inhibitor Angiotensin-converting enzyme inhibitors Autophagosome maturation Gene therapy Next generation sequencing Emery-Dreifuss muscular dystrophy COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Cardiology Rare diseases Cardiac conduction system AAV Cardiomyopathy Lamin A/C nuclei Myotubes LMNA gene Muscle MRI Heart failure INPP5K Butyrylcholinesterase Treatment delay Becker muscular dystrophy Cancer Laminopathie Acetyltransferase Maladies rares Allele-specific silencing therapy Errance diagnostique RNA interference COL6A1 Laminopathies